Cargando…

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

OBJECTIVE: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people with multiple sclerosis (PwMS). METHODS: We retrospectively collected data of PwMS with suspected or confirmed COVID‐19. All...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sormani, Maria P., De Rossi, Nicola, Schiavetti, Irene, Carmisciano, Luca, Cordioli, Cinzia, Moiola, Lucia, Radaelli, Marta, Immovilli, Paolo, Capobianco, Marco, Trojano, Maria, Zaratin, Paola, Tedeschi, Gioacchino, Comi, Giancarlo, Battaglia, Mario A., Patti, Francesco, Salvetti, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013440/ https://www.ncbi.nlm.nih.gov/pubmed/33480077 http://dx.doi.org/10.1002/ana.26028

Ejemplares similares

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
por: Sormani, Maria Pia, et al.
Publicado: (2021)

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
por: Ponzano, Marta, et al.
Publicado: (2022)

DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
por: Sormani, Maria Pia, et al.
Publicado: (2021)

Lung involvement correlates with disability in MS patients with COVID-19 pneumonia
por: Immovilli, Paolo, et al.
Publicado: (2022)

An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases
por: Salvetti, Marco, et al.
Publicado: (2019)

The Italian multiple sclerosis register
por: Trojano, Maria, et al.
Publicado: (2018)

Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
por: Schiavetti, Irene, et al.
Publicado: (2022)

The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
por: Ponzano, Marta, et al.
Publicado: (2022)

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis
por: Vabanesi, Marco, et al.
Publicado: (2019)

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
por: Mosconi, Paola, et al.
Publicado: (2023)

Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
por: Comi, Giancarlo, et al.
Publicado: (2013)

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
por: Iaffaldano, Pietro, et al.
Publicado: (2022)

Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
por: Zaratin, Paola, et al.
Publicado: (2022)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

Coronavirus disease 2019 in Latin American patients with multiple sclerosis
por: Fragoso, Yara D., et al.
Publicado: (2021)

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
por: Comi, Giancarlo, et al.
Publicado: (2020)

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015)

COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
por: Albanese, Angela, et al.
Publicado: (2022)

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
por: Pecori, Chiara, et al.
Publicado: (2014)

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
por: Sormani, Maria Pia, et al.
Publicado: (2021)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study
por: Genchi, Angela, et al.
Publicado: (2023)

Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
por: Fox, Robert J, et al.
Publicado: (2012)

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies
por: Iaffaldano, Pietro, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
por: Sormani, Maria Pia, et al.
Publicado: (2022)

Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015)

Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis
por: Ponzio, Michela, et al.
Publicado: (2015)

Changes in cortical motor outputs after a motor relapse of multiple sclerosis
por: Chieffo, Raffaella, et al.
Publicado: (2019)

Patients with multiple sclerosis: a burden and cost of illness study
por: Battaglia, Mario Alberto, et al.
Publicado: (2022)

Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning
por: Acquaviva, Massimo, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis and Multiple Sclerosis Overlap: A Case Report
por: Trojsi, Francesca, et al.
Publicado: (2012)

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
por: Dalla Costa, Gloria, et al.
Publicado: (2019)

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study
por: Pastò, Luisa, et al.
Publicado: (2012)

Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
por: Trojsi, Francesca, et al.
Publicado: (2015)

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression
por: Scandurra, Cristiano, et al.
Publicado: (2023)

Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a
por: Battaglini, Marco, et al.
Publicado: (2022)

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study
por: Giannini, Marta, et al.
Publicado: (2012)

Quantitative assessment of finger motor performance: Normative data
por: Signori, Alessio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bc3hd7j6jj7nc6tnh93h8h8jm1